Crown Holdings, Inc. (CCK) Stock Price & Analysis
Crown Holdings, Inc. (CCK) closed at USD 119.26 on Thursday, October 22, 2026, up 2.62% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 116.22; the Oct 22, 2026 session ranged USD 115.72–119.88 on volume of 1,034,650 shares. Market capitalization is $12.97B, with a 52-week range of USD 91.31–122.91 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CCK.md
Latest Earnings Results (CCK)
Crown Holdings, Inc. (CCK) reported Q3 2026 results on Oct 19, 2026, 4:08:30 PM ET: adjusted EPS $2.39 vs. estimate $2.26 (beat), revenue $3.71B vs. estimate $3.45B (beat). Guidance: Full year adjusted diluted EPS guidance is $8.35 to $8.45 and Q4 adjusted diluted EPS is expected to be $1.63 to $1.73. Source: SEC 8-K filing. Nexqual published it 31 seconds after release. Read the SEC filing.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $2.39 (adjusted (non-GAAP) diluted) | $3.71B | Oct 19, 2026, 4:08:30 PM ET · on Nexqual +31 seconds | SEC 8-K filing |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (CCK)
- Last four reported quarters (through Jun 30, 2026): revenue $13.3B, net income $784M (5.9% margin), free cash flow $1.20B (SEC filings).
- 4 of 80 tracked superinvestors hold CCK (13F, Q2 2026): 0 new, 0 added, 3 reduced, 1 unchanged.
- Total return with dividends: 1Y +22.0% vs S&P 500 +14.9%; 5Y +20.0% vs S&P 500 +80.3%.
- Next earnings: 2026-10-19, EPS estimate USD 1.68, revenue estimate $3.37B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CCK)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $11.4B | $12.9B | $12.0B | $11.8B | $12.4B | $13.3B |
| Operating income | $1.36B | $1.34B | $1.27B | $1.42B | $1.55B | $1.63B |
| Net income | -$560M | $727M | $450M | $424M | $738M | $784M |
| EPS (diluted) | -$4.30 | $5.99 | $3.76 | $3.55 | $6.38 | — |
| Free cash flow | $89.0M | -$36.0M | $660M | $789M | $1.12B | $1.20B |
| Operating margin | 12.0% | 10.3% | 10.6% | 12.0% | 12.6% | 12.3% |
| Net margin | -4.9% | 5.6% | 3.7% | 3.6% | 6.0% | 5.9% |
| Revenue growth | +21.3% | +13.6% | -7.2% | -1.7% | +4.8% | — |
| Cash + short-term investments | $531M | $550M | $1.31B | $918M | $764M | — |
| Total debt | $6.19B | $6.90B | $7.46B | $6.14B | $5.88B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CCK)
P/E at fiscal year-ends: Dec 2025 16.1x, Dec 2024 23.3x, Dec 2023 24.5x.
Superinvestors (SEC 13F-HR, Q2 2026) (CCK)
4 of 80 tracked investors hold CCK. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Thomas Gayner | Markel Group | 0.19% | $24.6M | Unchanged |
| Jensen Investment Management | 0.14% | $5.9M | Reduced -7.6% | |
| Bill Nygren | Oakmark Funds | 0.03% | $21.3M | Reduced -0.4% |
| Christopher Davis | Davis Advisors | <0.01% | $612K | Reduced -36.2% |
Analysts (CCK)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-21 | UBS | Target raised | Neutral | $116 → $118 |
| 2026-10-21 | Citigroup | Target raised | Buy | $137 → $139 |
| 2026-10-19 | Wells Fargo | Target lowered | Equal-Weight | $127 → $126 |
| 2026-10-05 | UBS | Target lowered | Neutral | $123 → $116 |
| 2026-09-18 | JP Morgan | Upgrade | Neutral → Overweight | $121 |
| 2026-07-24 | RBC Capital | Target raised | Outperform | $131 → $135 |
| 2026-07-22 | Wells Fargo | Target raised | Equal-Weight | $117 → $127 |
| 2026-07-22 | UBS | Target raised | Neutral | $115 → $123 |
| 2026-07-22 | BMO Capital | Target raised | Outperform | $130 → $135 |
| 2026-07-22 | Truist Securities | Target raised | Buy | $129 → $141 |
| 2026-07-22 | JP Morgan | Downgrade | Overweight → Neutral | $107 → $121 |
| 2026-07-22 | Baird | Target raised | Neutral | $120 → $130 |
Total return (dividends reinvested) (CCK)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +22.0% | +20.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +22.1% | +3.7% |
| Volatility (annualized) | 25.1% | 28.7% |
| Max drawdown | -20.2% (Mar 2026→Jun 2026) | -47.2% (Mar 2022→Oct 2022) |
CCK analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $1.68 | $1.80 | -6.8% | $3.37B | 12 |
| Next quarter (ends Mar 2027) | $1.88 | $1.90 | -1.1% | $3.36B | 10 |
| Current fiscal year (ends Dec 2026) | $8.41 | $8.38 | +0.4% | $14.01B | 14 |
| Next fiscal year (ends Dec 2027) | $9.08 | $9.03 | +0.5% | $14.29B | 14 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 119.26 |
|---|---|
| Change | ▲ 2.62% (up) |
| Previous Close | USD 116.22 |
| Open | USD 116.08 |
| Day Range | USD 115.72 – 119.88 |
| 52-Week Range | USD 91.31 – 122.91 |
| Volume | 1,034,650 shares |
| Market Cap | $12.97B |
| Exchange | NYQ |
Technical Analysis (CCK)
Nexqual's technical model rates CCK "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.72 (overbought) |
| vs SMA50 | Above (USD 112.82) |
| MACD | 1.37 (positive) |
Earnings (CCK)
| Next Earnings Date | 2026-10-19 |
|---|---|
| EPS Estimate | USD 1.68 |
| Revenue Estimate | $3.37B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 2.39 vs est 2.26 ▲ beat |
| 2026-06-30 | USD 2.49 vs est 2.16 ▲ beat |
| 2026-03-31 | USD 1.86 vs est 1.75 ▲ beat |
| 2025-12-31 | USD 1.74 vs est 1.7 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (CCK)
| Total Revenue | $13.77B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +15.90% |
| Gross Margin | +20.18% |
| Operating Margin | +11.99% |
| Profit Margin | +5.78% |
| ROE | +27.13% |
| Debt / Equity | 1.69 |
| Current Ratio | 1.14 |
| Total Cash | $629.00M |
| Total Debt | $5.85B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.20B (9.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (CCK)
Nexqual rates Crown Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Mixed — Revenue +4.8% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 20%, operating 12% (last 12 months) |
| Balance Sheet | Weak — $656M cash and investments vs $6.02B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $1.20B (last 4 quarters to Jun 2026, SEC), 9% margin |
| Efficiency | Strong — ROE 27%, ROA 7.1% |
Ownership (CCK)
| Insider Ownership | +0.86% |
|---|---|
| Institutional Ownership | +101.48% |
| Shares Outstanding | 108.76M |
| Float | 105.71M |
| Short % of Float | +2.65% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SLGN | Silgan Holdings Inc. | USD 39.76 | ▲ 2.05% |
| OI | O-I Glass, Inc. | USD 6.41 | ▲ 6.13% |
| ATR | AptarGroup, Inc. | USD 128.1 | ▲ 1.97% |
| PKG | Packaging Corporation of Americ | USD 248.92 | ▲ 4.15% |
| GPK | Graphic Packaging Holding Compa | USD 9.04 | ▲ 7.75% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt